NCT04247685View on ClinicalTrials.gov

Evaluation of MRI-conditional 12-lead ECG

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Atrial Fibrillation
Interventions
DEVICE

12-lead ECG monitoring device (MiRTLE Medical)

12-lead ECG monitoring device produced by a Massachusetts-based medical device company MiRTLE Medical is the experimental device;

DEVICE

3-lead ECG gating system

3-lead ECG gating system is the placebo/standard of care

Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Center, Toronto

All Listed Sponsors
lead

Dr. Graham Wright

OTHER